Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VEM Vermögensverwaltung GmbH is the primary holding company and family office for the Merckle family, one of Germany's most prominent industrial dynasties. The firm manages a multi-billion euro portfolio with a significant strategic focus on the healthcare and life sciences sectors. Its most notable healthcare asset is the Phoenix Group (Phoenix Pharmahandel), which stands as one of Europe's largest pharmaceutical wholesalers and retail pharmacy operators. Historically, VEM was the parent company of the major generics manufacturer Ratiopharm until its high-profile sale to Teva Pharmaceutical Industries in 2010. Beyond healthcare, the company maintains substantial interests in industrial sectors, including electric motors through the VEM Group and specialized vehicles via Kässbohrer Geländefahrzeug.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VEM Vermögensverwaltung.